| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |